State Street’s Unity Biotechnology UBX Stock Holding History

State Street’s Portfolio UBX Stock Details UBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-37,824	Closed	-$14.4K	–	4377
2025 Q2	$14.4K	Hold	37,824	–	–	﹤0.01%	4224
2025 Q1	$39.3K	Hold	37,824	–	–	﹤0.01%	4129
2024 Q4	$36.9K	Hold	37,824	–	–	﹤0.01%	4153
2024 Q3	$55.6K	Hold	37,824	–	–	﹤0.01%	4082
2024 Q2	$51.1K	Hold	37,824	–	–	﹤0.01%	4134
2024 Q1	$62K	Hold	37,824	–	–	﹤0.01%	4122
2023 Q4	$73K	Hold	37,824	–	–	﹤0.01%	4121
2023 Q3	$90.8K	Hold	37,824	–	–	﹤0.01%	4135
2023 Q2	$96.5K	Sell	37,824 -340	-0.9%	-$898	﹤0.01%	4252
2023 Q1	$62.2K	Buy	38,164 +13,300	+53%	+$53.3K	﹤0.01%	4450
2022 Q4	$68.1K	Buy	24,864 +7,600	+44%	+$22.1K	﹤0.01%	4477
2022 Q3	$68K	Buy	17,264 +4,220	+32%	+$26.6K	﹤0.01%	4584
2022 Q2	$74K	Buy	13,044 +2,260	+21%	+$18.9K	﹤0.01%	4631
2022 Q1	$121K	Buy	10,784 +510	+5%	+$5.72K	﹤0.01%	4584
2021 Q4	$150K	Hold	10,274	–	–	﹤0.01%	4458
2021 Q3	$308K	Hold	10,274	–	–	﹤0.01%	4186
2021 Q2	$477K	Sell	10,274 -49,344	-83%	-$2.38M	﹤0.01%	3873
2021 Q1	$3.58M	Sell	59,618 -2,900	-5%	-$198K	﹤0.01%	3192
2020 Q4	$3.28M	Buy	62,518 +3,458	+6%	+$167K	﹤0.01%	3161
2020 Q3	$2.04M	Buy	59,060 +1,447	+3%	+$91.6K	﹤0.01%	3184
2020 Q2	$5M	Buy	57,613 +11,159	+24%	+$827K	﹤0.01%	2758
2020 Q1	$2.69M	Sell	46,454 -2,378	-5%	-$150K	﹤0.01%	2927
2019 Q4	$3.52M	Buy	48,832 +6,357	+15%	+$448K	﹤0.01%	3018
2019 Q3	$2.59M	Sell	42,475 -864	-2%	-$61.1K	﹤0.01%	3122
2019 Q2	$4.12M	Buy	43,339 +1,532	+4%	+$130K	﹤0.01%	2934
2019 Q1	$3.39M	Buy	41,807 +1,642	+4%	+$186K	﹤0.01%	2936
2018 Q4	$6.53M	Buy	40,165 +31,573	+367%	+$4.19M	﹤0.01%	2600
2018 Q3	$1.4M	Buy	8,592 +4,582	+114%	+$754K	﹤0.01%	3347
2018 Q2	$604K	Buy	+4,010	New	+$586K	﹤0.01%	3449

Other funds holding UBX

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

AWM

AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

State Street's UBX Position: Q3 2025 in Review

State Street sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 37,824 shares — an estimated $14.4K sold.

State Street first reported a position in UBX in Q2 2018 and held it in 29 quarters. The position peaked at $6.53M in Q4 2018. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

State Street reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
State Street sold 37,824 Unity Biotechnology shares in Q3 2025, an estimated $14.4K.
State Street first reported a position in Unity Biotechnology in Q2 2018 and held it in 29 quarters.
State Street's Unity Biotechnology position peaked at $6.53M in Q4 2018.
6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.